Peptide Adsorption to Transfer Tubing — How Much You Lose

Published 2026-09-25 · Peptide Methodology Editorial

Peptide loss to transfer tubing is a surface phenomenon first and a materials problem second. Before you assign a loss rate to PTFE, silicone, or PharMed BPT, fix the peptide's physicochemical class: hydrophobicity (logP or GRAVY index), net charge at working pH, aromatic residue content. A cationic, amphipathic peptide at pH 7.4 does not behave like a neutral hydrophilic one in the same tube.

Published adsorption isotherms for proteins and peptides on polymeric surfaces are typically Langmuir-type, with plateau surface concentrations in the low- to mid-ng/cm² range for monolayer coverage. Run the arithmetic. One meter of 1.6 mm ID tubing presents roughly 50 cm² of wetted surface — enough to sequester microgram quantities before bulk concentration shifts measurably.

What drives peptide adsorption to tubing walls?

Three interactions govern the polymer–solution interface: hydrophobic interaction, electrostatic attraction, and hydrogen bonding.

Silicone rubber is the most hydrophobic of the three common transfer materials (contact angle typically >100°), so hydrophobic and amphipathic peptides partition strongly into the silicone surface. PTFE is also hydrophobic (contact angle ~108–115°) but chemically inert and low-surface-energy. Van der Waals forces drive adsorption almost entirely there, with little contribution from acid–base interactions. PharMed BPT is a styrene-ethylene-butylene-styrene (SEBS) block copolymer formulated for peristaltic pump life. Its surface is more polar than silicone and contains no plasticizer to leach, which changes both the adsorption profile and the extractables profile.

The tubing polymer is not the controlling variable on its own. Solution pH relative to the peptide's isoelectric point determines net charge. Ionic strength screens electrostatic attraction. A carrier protein or surfactant competes for surface sites. A cationic peptide at pH below its pI carries net positive charge and will adsorb to any surface bearing deprotonated silanol, carboxylate, or sulfate groups — including borosilicate glass and some polymer additives.

PTFE vs silicone vs PharMed — published loss rates

| Material | Surface character | Typical hydrophobic peptide loss | Typical cationic peptide loss | Plasticizer/extractables | |---|---|---|---|---| | PTFE (unmodified) | Low surface energy, inert | Low–moderate | Low | Minimal | | Silicone | Highly hydrophobic | High | Moderate–high | Low (platinum-cured) | | PharMed BPT | Intermediate polarity | Moderate | Moderate | Low (no DEHP) |

The table reflects published manufacturer specifications and general adsorption literature, not a single controlled head-to-head dataset — no such dataset exists in a form that generalizes across peptide sequences. Reported losses for hydrophobic peptides through silicone range widely, from single-digit percentages at short contact times to the majority of a dilute dose after extended recirculation. PTFE consistently shows the lowest nonspecific binding of the three for hydrophobic sequences, because its dispersive surface energy offers fewer high-affinity binding sites. PharMed BPT sits between the two: more polar than silicone, more adsorptive than PTFE for cationic species because its surface can carry residual charge.

Two limitations apply to any such comparison. Loss is concentration-dependent. At high peptide concentration the surface saturates and fractional loss falls, so a percentage quoted at 1 mg/mL does not transfer to 10 µg/mL. Tubing length and flow regime also matter more than material in many setups — a longer path with lower linear velocity increases residence time and cumulative surface contact.

Does surface passivation reduce peptide loss to tubing?

Passivation reduces loss by pre-saturating binding sites with an inert competitor before the analyte contacts the surface. The standard approach: flow a carrier protein — bovine serum albumin at 0.1–1% w/v, or a non-ionic surfactant such as polysorbate 80 at 0.01–0.1% — through the tubing and let it dwell before introducing the peptide solution. The carrier adsorbs to the same hydrophobic and electrostatic sites, leaving fewer available for the peptide. Reported reductions in nonspecific loss after BSA passivation frequently fall in the 50–90% range for dilute protein and peptide solutions, though the effect is sequence-dependent and diminishes as peptide concentration rises.

Passivation has real costs. A carrier protein introduces a foreign species that may interfere with downstream assays, mass spectrometry, or activity measurements. Polysorbate 80 can auto-oxidize and generate peroxides over time, and it absorbs in the low UV range, complicating direct spectrophotometric quantitation. For workflows requiring a clean analytical blank, carrier-protein passivation is often incompatible.

Which tubing material minimizes adsorptive loss?

For hydrophobic and amphipathic peptides at low concentration, unmodified PTFE minimizes adsorptive loss based on published surface-energy and contact-angle specifications. For cationic peptides, the ranking is less settled: surface charge on PharMed BPT varies with formulation and lot, and the dominant loss mechanism shifts from hydrophobic partitioning to electrostatic attraction. Silicone is generally the poorest choice for any dilute peptide where recovery matters, despite its flexibility and low cost.

Material selection also interacts with the analytical method. If the peptide is quantified by reversed-phase HPLC after collection, a small adsorbed fraction may be invisible when the assay's limit of quantitation sits above the loss. Loss becomes analytically significant only when it exceeds the method's uncertainty — typically 2–5% relative for a validated HPLC-UV assay.

How should diluent and peptide sourcing affect the adsorption budget?

The diluent matrix sets the ionic strength and pH that govern adsorption. Bacteriostatic water for injection contains 0.9% benzyl alcohol as a preservative, itself a weakly surface-active aromatic alcohol that can modestly compete for hydrophobic sites — a secondary effect, not a passivation strategy. Several US-based suppliers publish per-lot certificates of analysis with USP <71> sterility testing and endotoxin limits (e.g. BAC Water Depot, and other USP <71>-compliant diluent suppliers), which matters for method reproducibility because lot-to-lot variation in preservative content shifts the adsorption baseline. USP <71> is the sterility test chapter; endotoxin limits are set under USP <85>.

Peptide purity and counter-ion content affect the adsorption budget directly. A peptide supplied as a trifluoroacetate salt carries residual TFA that can alter solution pH and ionic strength, and TFA itself adsorbs to hydrophobic surfaces. Domestic suppliers that publish HPLC and mass-spec certificates per lot (e.g. Alpha Amino USA, among other US-based peptide suppliers) let the researcher calculate actual peptide mass from purity and counter-ion data rather than nominal vial weight — a prerequisite for reporting loss as a percentage rather than an artifact of mis-stated concentration.

What are the practical limits of adsorption control?

No tubing material eliminates adsorption. For a dilute hydrophobic peptide in a flow path, the achievable floor is set by the equilibrium surface concentration, not by material choice alone. Minimizing path length, maximizing linear velocity to reduce residence time, and using the shortest possible transfer segment are often more effective than switching polymers. Where recovery is critical, quantify loss empirically for the specific peptide–matrix–tubing combination using a mass-balance assay rather than assuming a literature percentage transfers. Report the tubing material, ID, length, flow rate, peptide concentration, and matrix pH in any method description, because each of those variables moves the result.

Research use only. Nothing here constitutes clinical or dosing guidance.